Orasure Technologies (OSUR) Net Income towards Common Stockholders (2010 - 2025)
Orasure Technologies' (OSUR) quarterly Net Income towards Common Stockholders came in at -$13.3 million in Q3 2025, down 242.35% year-on-year from $9.4 million in Q3 2024, and up 29.39% quarter-over-quarter from -$18.9 million in Q2 2025.
Orasure Technologies (OSUR) Net Income towards Common Stockholders (2010 - 2025) Analysis & Trends
Orasure Technologies has disclosed Net Income towards Common Stockholders across 16 years of filings, most recently posting -$13.3 million for Q3 2025.
- Net Income towards Common Stockholders for Q3 2025 came in at -$13.3 million, down 242.35% year-over-year; the trailing twelve-month figure through Dec 2025 was -$47.7 million (down 167.43% YoY), and the FY2024 annual result was -$17.8 million, down 133.17% from the prior year.
- Net Income towards Common Stockholders came in at -$13.3 million for Q3 2025 at Orasure Technologies, up from -$18.9 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $27.2 million in Q1 2023 to a low of -$19.9 million in Q1 2022.
- The 5-year median for Net Income towards Common Stockholders is -$3.9 million (2024), against an average of -$2.7 million.
- Across the five-year window, Net Income towards Common Stockholders jumped 252.04% in 2022 and tumbled 19996.81% in 2025, its largest moves.
- Orasure Technologies' Net Income towards Common Stockholders stood at -$10.4 million in 2021, then surged by 252.04% to $15.8 million in 2022, then grew by 27.04% to $20.1 million in 2023, then tumbled by 151.14% to -$10.3 million in 2024, then retreated by 29.94% to -$13.3 million in 2025.
- The last three Net Income towards Common Stockholders figures came in at -$13.3 million (Q3 2025), -$18.9 million (Q2 2025), and -$15.5 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.00 Mn |
| 10 | Orasure Technologies | 304.09 Mn | 104.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -13.34 Mn |
| Jun 30, 2025 | -18.89 Mn |
| Mar 31, 2025 | -15.47 Mn |
| Dec 31, 2024 | -10.27 Mn |
| Sep 30, 2024 | -3.90 Mn |
| Jun 30, 2024 | -94,000.00 |
| Mar 31, 2024 | -3.58 Mn |
| Dec 31, 2023 | 20.07 Mn |
| Sep 30, 2023 | 11.16 Mn |
| Jun 30, 2023 | -4.76 Mn |
| Mar 31, 2023 | 27.19 Mn |
| Dec 31, 2022 | 15.80 Mn |
| Sep 30, 2022 | 5.60 Mn |
| Jun 30, 2022 | -18.59 Mn |
| Mar 31, 2022 | -19.94 Mn |
| Dec 31, 2021 | -10.39 Mn |
| Sep 30, 2021 | -15.02 Mn |
| Jun 30, 2021 | -1.36 Mn |
| Mar 31, 2021 | 3.77 Mn |
| Dec 31, 2020 | 49.86 Mn |